Natural product-based therapy for Deafness: A therapeutic mix encompassing β-Cryptoxanthin (BCX), Cholecalciferol, Ajoene and DIM (BCXCAD) increases the expression of ATG5 (Autophagy-related 5), prevents aggregation of proteins in inclusion bodies, inhibits hair cell degeneration, and improves hearing loss via up regulation of its target genes, 14/October/2017, 10.09 am
https://genomediscovery.org/wp-content/uploads/2017/10/A-pharmaceutical-mix-encompassing-β-Cryptoxanthin-Cholecalciferol-Ajoene-and-DIM-βCXCAD-protects-against-hearing-loss-through-induction-of-ATG51.jpg
960
720
Dr Boomi's Genom-2-Discovery Center
https://genomediscovery.org/wp-content/uploads/2017/10/A-pharmaceutical-mix-encompassing-β-Cryptoxanthin-Cholecalciferol-Ajoene-and-DIM-βCXCAD-protects-against-hearing-loss-through-induction-of-ATG51.jpg
What we say: Dr L Boominathan PhD, Director-cum-chief Scientist of GBMD, reports that: Natural product-based therapy for Deafness: A therapeutic mix encompassing β-Cryptoxanthin (BCX), Cholecalciferol, Ajoene and DIM (BCXCAD) increases the expression of ATG5…
read more